Showing results (21-30 of 263) with videos related to

Sort By:
Pageof 27
The Journal of Allergy and Clinical Immunology. in Practice|March 11, 2014
Allergen immunotherapy: clinical outcomes assessmentMelina Makatsori, Oliver Pfaar, Moises A Calderon
Allergologie Select|January 22, 2024
Allergen immunotherapy for allergic asthmaJ Christian Virchow, Oliver Pfaar, Marek Lommatzsch
Allergologie Select|March 17, 2023
Real-life evidence in allergen immunotherapy: Moving forward with mHealth appsBernardo Sousa-Pinto, Oliver Pfaar, Jean Bousquet
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|February 3, 2015
Safety and effect on reported symptoms of depigmented polymerized allergen immunotherapy: a retrospective study of 2927 paediatric patientsOliver Pfaar, Angelika Sager, Douglas S Robinson
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|September 17, 2009
Safety aspects of Cluster immunotherapy with semi-depot allergen extracts in seasonal allergic rhinoconjunctivitisOliver Pfaar, Ralph Mösges, Karl Hörmann, et al.
Allergologie Select|March 17, 2023
Clinical endpoints in allergen immunotherapy: State of the art 2022Roy Gerth van Wijk, Ludger Klimek, Oliver Pfaar
American Journal of Rhinology & Allergy|February 20, 2010
Safety of a depigmented, polymerized vaccine for the treatment of allergic rhinoconjunctivitis and allergic asthmaOliver Pfaar, Ludger Klimek, Angelika Sager, et al.
Current Allergy and Asthma Reports|April 1, 2014
Aspirin desensitization: useful treatment for chronic rhinosinusitis with nasal polyps (CRSwNP) in aspirin-exacerbated respiratory disease (AERD)?Ludger Klimek, Ralph Dollner, Oliver Pfaar, et al.
Current Opinion in Allergy and Clinical Immunology|April 23, 2015
Clinically relevant outcome measures for new pharmacotherapy, allergen avoidance and immunotherapy trials in allergic rhinoconjunctivitisOliver Pfaar, Ludger Klimek, Roy Gerth van Wijk
Clinical and Translational Allergy|November 25, 2023
A high-dose, depigmented polymerized birch pollen extract for subcutaneous allergen immunotherapy has a favourable efficacy/safety ratioOliver Pfaar, Angelika Sager, Ralph Mösges, et al.
Pageof 27